Zavicefta is indicated for the treatment of the following infections in adults (see Precautions and Pharmacology: Pharmacodynamics under Actions): Complicated intra-abdominal infection (cIAI), in combination with metronidazole.
Complicated urinary tract infection (cUTI), including pyelonephritis.
Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP).
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Zavicefta should be used in combination with an antibacterial agent(s) active against Gram-positive and/or anaerobic pathogens when these are known or suspected to be contributing to the infectious process.